NSEShareholders meeting2d ago · 29 Jul 2026, 07:59 pm

Shareholders meeting

Rainbow Childrens Medicare Limited · RAINBOW

✦ AI SummaryMgmt Change

Rainbow Children's Medicare Limited held its 28th Annual General Meeting on July 29, 2026, through video conference, with 63 members present, including 6 promoters and 57 public shareholders.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Rainbow Childrens Medicare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 29, 2026

Attachments (1)

📄

RAINBOWUSER_29072026195912_Intimationproceedings.pdf

pdf

Download →
View document text
Rainbow® Children's ~ BirthRighf Hospital ~ - BY RAINBOW HOSPITALS WOMEN CARE I CHILD CARE I FERTILITY July 29, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, Plot No. C/1, G Block, Corporate Relationship Department, Bandra Kurla Complex, Bandra (E), Phiroze Jeejeebhoy Towers, Mumbai – 400 051. Dalal Street, Mumbai – 400001. Symbol: RAINBOW Scrip Code: 543524 Sub: Proceedings of the 28th Annual General Meeting of the Company. Dear Sir/ Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), we wish to inform you that the 28th Annual General Meeting ("AGM") of the Company was held today, i.e., Wednesday, July 29, 2026, at 10:00 A.M. (IST) through Video Conference ("VC")/ Other Audio-Visual Means ("OAVM"), in compliance with the applicable provisions of the Companies Act, 2013 and the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. The AGM concluded at 11:00 P.M (IST). In this regard, please find attached proceedings of the AGM as required under Regulation 30 of the SEBI Listing Regulations. This is for your information and records. Thanking You, Yours Faithfully, For Rainbow Children’s Medicare Limited Shreya Mitra Company Secretary and Compliance Officer Encl.: As above Rainbow Children's Medicare Limited Registered Office: 8-2-120/103/1, Survey No. 403, Road No. 2, Banjara Hills, Hyderabad- 500034, Telangana CIN :L85110TG 1998PLC029914 Q Corporate Office: 8-2-19/1/A, Daulet Arcade, Road No. 11, Banjara Hills, Hyderabad- 500034, Telangana G info@rainbowhospitals.in \;' 1800 2122 iffil www. rainbowhospitals.in OUR PRESENCE: BENGALURU CHENNAI DELHI GUWAHATI HYDERABAD RAJAHMUNDRY VIJAYAWADA VISAKHAPATNAM WARANGAL Summary of Proceedings of the 28th Annual General Meeting of Rainbow Children’s Medicare Limited (“Company”) The 28th Annual General Meeting (“AGM/ Meeting”) of the Members of the Company was held today i.e., Wednesday, July 29, 2026 through Video Conferencing/ Other Audio-Visual Means (“VC/ OAVM”) in compliance with the applicable provisions of the Companies Act, 2013 and the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India in this behalf. The meeting commenced at 10:00 A.M (IST). The following Directors and Key Managerial Personnel(s) were present: Name Designation Location Dr. Ramesh Kancharla Chairman & Managing Director, Chairman of Business Hyderabad, Strategy & Investment Committee and Treasury Management India Committee and Member of Risk Management Committee, Stakeholders Relationship Committee, CSR & ESG Committee and TCWG Committee. Dr. Dinesh Kumar Chirla Whole-Time Director and Member of CSR & ESG Committee. Hyderabad, India Dr. Adarsh Kancharla Non - Executive Director and Member of Risk Management Hyderabad, Committee and CSR & ESG Committee. India Dr. Anil Dhawan Independent Director, Chairman of CSR & ESG Committee Hyderabad, and member of Audit Committee, Nomination & Remuneration India Committee, Stakeholders Relationship Committee and TCWG Committee. Mr. Aluri Srinivasa Rao Independent Director, Chairman of Nomination & Hyderabad, Remuneration Committee and member of Audit Committee, India Nomination & Remuneration Committee, Stakeholders Relationship Committee, Risk Management Committee, and TCWG Committee. Mr. Santanu Mukherjee Independent Director, Chairman of Audit Committee and Risk Hyderabad, Management Committee and member of Nomination & India Remuneration Committee, CSR & ESG Committee, Treasury Management Committee, Business Strategy & Investment Committee and TCWG Committee. Ms. Sundari R. Pisupati Independent Director, Chairperson of Stakeholders Hyderabad, Relationship Committee and member of Audit Committee, India Nomination & Remuneration Committee and CSR & ESG Committee, Business Strategy & Investment Committee and TCWG Committee. Mr. Abrarali Dalal Chief Executive Officer and Member of Risk Management Hyderabad, Committee, Business Strategy & Investment Committee and India TCWG Committee. Mr. Vikas Maheshwari Chief Financial Officer and Member of Risk Management Hyderabad, Committee, Treasury Management Committee and TCWG India Committee. Ms. Shreya Mitra Company Secretary & Compliance Officer. Hyderabad, India The details of number of Members present in the meeting are as follows: Promoter & Promoter Group Public Total 6 57 63 The moderator welcomed the Members to the 28th AGM of the Company and gave them the instructions for joining the meeting through video conference. Thereafter, Dr. Ramesh Kancharla, Chairman & Managing Director, Dr. Dinesh Kumar Chirla, Whole-time Director, Dr. Adarsh Kancharla, Non– Executive Director, Dr. Anil Dhawan, Mr. Aluri Srinivasa Rao, Mr. Santanu Mukherjee, Ms. Sundari R. Pisupati, Independent Directors, Mr. Abrarali Dalal, Chief Executive Officer, Mr. Vikas Maheshwari, Chief Financial Officer and Ms. Shreya Mitra, Company Secretary & Compliance Officer introduced themselves to the Members. Thereafter, the moderator confirmed the presence of the following: Mr. Chirag C Shah Director, M/s. S.R. Batliboi & Associates LLP, Statutory Auditors of the Company. Mr. K.V.S Subramanyam Practicing Company Secretary, Secretarial Auditor of the Company. Mr. Prabhat Naulakha Associate Director, M/s. Deloitte Touche Tohmatsu India LLP, Internal Auditors of the Company. Ms. K.V.N. Lavanya Designated Partner, M/s. Lavanya and Associates LLP, Cost Accountants, Cost Auditors of the Company. Thereafter, Ms. Shreya Mitra, Company Secretary & Compliance Officer, welcomed the Members who were participating in the Meeting through Video Conference and provided the general instructions to the members regarding participation in the AGM. She further informed that the Statutory Registers under the Companies Act, 2013 along with the other documents as mentioned in the AGM Notice are available for inspection by the members and also confirmed the presence of quorum. Thereafter, she requested Dr. Ramesh Kancharla to chair the meeting. Dr. Ramesh Kancharla, took the chair and welcomed the members and read out his speech. Dr. Ramesh Kancharla, further requested Mr. Abrarali Dalal, Chief Executive Officer of the Company, to address the shareholders of the Company. The Chairman also informed that the Statutory Auditors’ Report and Secretarial Auditors’ Report for the Financial Year ended March 31, 2026 did not contain any qualifications, observations or comments on financial transactions or matters which had adverse effect on the functioning of the Company and therefore, were not required to be read at the AGM. The notice of the AGM was, then, taken as read, as the same was already circulated to the Members. Thereafter, Ms. Shreya Mitra, Company Secretary & Compliance Officer, took up the following items of business, as per the Notice of AGM: S. No Details of Resolutions Type of Resolution (Ordinary/ Special) ORDINARY BUSINESS 1. To receive, consider and adopt the Audited Standalone Financial Ordinary statements of the Company for the Financial Year ended March 31, 2026, the reports of the Auditors and Board of Directors thereon and the Audited Consolidated Financial statements of the Company for the Financial Year ended March 31, 2026 and the report of the Auditors thereon. 2. To declare dividend of ₹3.5/- per Equity Share for the Financial Year Ordinary ended March 31, 2026. 3. To appoint a Director in place of Dr. Adarsh Kancharla (DIN: 08302615), Ordinary who retires by rotation and being eligible offers himself for re- appointment. SPECIAL BUSINESS 4. To ratify the remuneration payable to Cost Auditors for the Financial Ordinary Year 2026-27. 5. To consider review and approve the re-appointment of Dr. Ramesh Ordinary Kancharla (DIN: 00212270), Chairman and Managing Director of the Company. 6. To consider, review and approve the remuneration payable to Dr. Special Ram [Showing first 8,000 characters — download PDF for full document]